Chinese medical solution provider Medlinker has raised a RMB1 billion ($146.8 million) series D round led by China Capital Zhongcai Fund, an industrial fund management company jointly sponsored by China Investment Securities, Zhongcai Financial Holding Investment LTD and others.

Other investors of this round include Sequoia Capital, China Health Industry Investment Fund and Huaxing Capital.

Founded in 2014, Medlinker is specially designed for doctors who can share their expertise, experiences, and opinions with other elites in the industry through the platform. It connects over 500,000 verified doctors with healthcare institutions, pharmaceutical companies, patients and insurance firms, according to its website.

The ultimate objective of Medlinker is to grow into a comprehensive innovative medical enterprise covering the entire industry chain of Internet + medical health.